Ionis Pharmaceuticals IONS Debt Maturity - Thereafter
Debt Maturity - Thereafter at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's debt maturity - thereafter.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's debt maturity - thereafter?
- Ionis Pharmaceuticals (IONS) reported debt maturity - thereafter of $300K in Q4 2025.
- What does debt maturity - thereafter mean?
- The amount of debt principal due after the specified near-term maturity periods.
- How do you interpret debt maturity - thereafter?
- A large balance indicates long-term financial commitment, which can be beneficial if interest rates are locked in at favorable levels.
- How does debt maturity - thereafter compare across companies?
- Commonly reported in debt maturity tables for all companies with long-term capital structures.